Plasma galectin-3 (Gal-3) is elevated in, and drives, diverse inflammatory disorders, including cardiovascular diseases, diabetes, and cancer where it promotes tumor growth and metastasis. This study showed for the first time that two apheresis systems performing a procedure where blood is removed, separated, filtered and returned, were able to remove a modest amount of galectin-3.

Pachymic acid, a purified triterpene extracted from the medicinal fungus Poria cocos, used in traditional Asian medical systems, was found to have significant activity against chemotherapy-resistant pancreatic cancer, in both cell culture and animal models.

Honokiol, a bioactive compound isolated from Magnolia officinalis bark, strongly inhibited the process of metastasis, including invasion and colony formation in highly metastatic renal cancer cells.

Oral dichloroacetate (DCA) is a compound currently under investigation as an adjuvant for treatment of various cancers. This case series describes positive clinical results obtained in advanced cancer patients with the use of DCA in an intravenous form, allowing for more effective and less toxic applications.

This article describes the importance of the complex community of microorganisms which co-habit the body, with emerging research continuing to uncover profound effects on all aspects of health and development.

This case report describes for the first time the use of galectin-3 blood testing to assess and monitor a cancer patient’s progress.

Triterpenes from P. cocos, a medicinal mushroom widely used in traditional Asian medicine, demonstrated anticancer and anti-invasive effects in human pancreatic cancer cells by downregulating multiple signaling pathways and promoting cell cycle arrest.

Oral administration of a dietary supplement containing medicinal mushrooms, medicinal herbs and biologically active nutritional compounds, was found to suppress tumor growth and breast-to-lung metastasis in a model of human breast cancer cells implanted in mice.

This study showed that when modified citrus pectin was combined with specific breast or prostate formulas, the effects were synergistic, showing greater benefits than either compound alone in inhibiting the metastasis of human breast and prostate cancer cells.

A polybotanical prostate formula, when given orally to mice implanted with aggressive human hormone refractory (independent) prostate cancer cells, showed significant anticancer activity by suppressing the growth of prostate cancer via modulation of gene expression, without any signs of toxicity.

MCP was found to activate T-cytotoxic cells and B-cells, and induced significant activation of NK cells, which were effective in inducing cancer cell death.

Treatment of highly invasive human hormone refractory (independent) prostate cancer cells with a dietary supplement for prostate health, potently inhibited cancer cell proliferation and reduced metastatic behavior, by downregulating the expression of multiple genes controlling cancer cell behavior.

This study showed Modified Citrus Pectin induced a dramatic decrease in blood serum levels of lead, (161% average change), and a dramatic increase in lead excretion in a 24-hour urine collection, (132% average change), with no toxicity or side effects.

This pilot trial provides the first evidence that oral administration of modified citrus pectin (MCP) significantly increases the urinary excretion of toxic metals in subjects with a ‘normal’ body load of metals. In the first 24 hours of MCP administration the urinary excretion of arsenic increased 130%; on day 6, cadmium showed a significant 150% urinary excretion, with a dramatic 560% increase in lead excretion.